SCHEMBL22948136

SCHEMBL22948136

c1ccc(-c2cc(-c3ccc(-c4ccc(-c5ccc6c(c5)[Si](c5ccccc5)(c5ccccc5)c5ccccc5-6)cc4)cc3)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.40
MEN1 O00255 7/20 0.39
KMT2A Q03164 7/20 0.39
MCL1 Q07820 3/20 0.37
MYC P01106 1/20 0.36
CTRC Q99895 1/20 0.35
PDK2 Q15119 1/20 0.35
MAPT P10636 4/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
RAB9A P51151 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
LMNA P02545 2/20 0.35
APAF1 O14727 1/20 0.35
NPC1 O15118 1/20 0.35
THRB P10828 1/20 0.35
XBP1 P17861 1/20 0.35
PTBP1 P26599 1/20 0.35
HTT P42858 1/20 0.35
GALK1 P51570 1/20 0.35
BLM P54132 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22948135 0.96 MEN1 (0.37) CYP19A1MEN1KMT2AMCL1MYC
SCHEMBL13203079 0.93 CYP19A1 (0.39) CYP19A1MEN1KMT2AMCL1MYC
SCHEMBL15501956 0.89 MEN1 (0.43) MEN1KMT2AMAPTSMN1; SMN2L3MBTL1
SCHEMBL17693947 0.88 MEN1 (0.44) MEN1KMT2AMAPTSMN1; SMN2L3MBTL1
SCHEMBL22949336 0.85 MEN1 (0.39) MEN1KMT2APDK2MAPTSMN1; SMN2
SCHEMBL22572806 0.85 MEN1 (0.39) MEN1KMT2APDK2MAPTSMN1; SMN2
SCHEMBL22947694 0.85 MEN1 (0.39) MEN1KMT2APDK2MAPTSMN1; SMN2
SCHEMBL22948247 0.83 CYP19A1 (0.38) CYP19A1MEN1KMT2AMCL1MYC
SCHEMBL20087482 0.83 NPC1 (0.48) MEN1KMT2APDK2MAPTSMN1; SMN2
SCHEMBL22572812 0.82 MEN1 (0.39) MEN1KMT2AMAPTSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 CYP19A1 174/4885MEN1 2439/4885KMT2A 2115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.